1. Rotavirus infection;Crawford;Nat Rev Dis Primers,2017
2. Una valutazione economica completa della vaccinazione estensiva contro i rotavirus con il vaccino RIX4414 a livello nazionale e regionale in Italia;Vitale;Ann Ig,2013
3. GlaxoSmithKline Biologicals. Rotarix: EPAR - product information. 2006. European Medicines Agency. Last update: January 14, 2016 Accessed: December 2, 2021. Available from: https://www.ema.europa.eu/en/documents/product-information/rotarix-epar-product-information_en.pdf.
4. MSD VACCINS. RotaTeq: EPAR - product Information. 2006. European Medicines Agency. Last update: May 18, 2011 Accessed: December 2, 2021. Available from: https://www.ema.europa.eu/en/documents/product-information/rotateq-epar-product-information_en.pdf.
5. National Vaccine Prevention Plan 2017–2019 [Piano nazionale prevenzione vaccinale 2017–19]. Ministry of Health, 2017. Accessed: December 2, 2021. Available from: http://www.salute.gov.it/portale/vaccinazioni/dettaglioContenutiVaccinazioni.jsp?lingua=italiano&id=4828&area=vaccinazioni&menu=vuoto.